|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Mycoplasma pneumoniae IgM ELISA | Acid Labile Subunit (ALS) ELISA Assay | Amyloidß (1-43) (FL) ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Soluble Leptin Receptor (sLEP-R) ELISA |
| Citations | | | | | |
| Catalog Number | IB79886 | E35 | 27710 | 27600 | R07 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Mycoplasma pneumoniae IgM ELISA is intended for the determination of IgM class antibodies against Mycoplasma pneumoniae in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of Acid Labile Subunit (ALS) in serum and plasma (heparin, EDTA, citrate). For research use only, not for use in diagnostic procedures. | Sandwich enzyme-linked immune-sorbent assay (ELISA) for the determination of human Amyloid ß (1-43) in cerebrospinal fluid, brain extract of Tg mouse and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Enzyme immunoassay (ELISA) for the determination of soluble human leptin receptor (sLEP-R) in human serum or plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Vasopressin | Immunoglobulin A (IgA) | Anti-Etanercept (Enbrel®) | Metanephrine / Normetanephrine | Parvovirus B19 IgG |
| Sample Type | Blood Plasma, Urine | Serum, plasma, tissue homogenates and other biological fluids. | Serum and plasma. | Urine | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 1.5 to 40.0 mU/mL ALS | 2.34 to 150 pg/mL | 1.56 to 100.0 ng/mL | 0 / 3.125 – 150 ng/mL |
| Sensitivity | 0.5 pmol/L | 0.469 ng/ml | 40 ng/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 98% |
| Assay Time | 1 hr, 45 mins (incubation) | 3 hrs (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hours (incubation) | 5 hour total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |